bf/NASDAQ:BGNE_icon.jpeg

COM:BEIGENE

BeiGene

  • Stock

USD

Last Close

194.56

22/11 21:00

Market Cap

15.82B

Beta: -

Volume Today

222.26K

Avg: -

  • name

    BeiGene, Ltd.
  • homepage url

    www.beigene.com
  • country

    USUnited States
  • employee count

    10,000
  • sector

    Healthcare
  • industry

    Biotechnology
  • revenue

    2.46B

Description

BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplastic syndromes, chronic myelomonoc...Show More

peer of

competitor of